SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
23.05
+0.35 (1.54%)
At close: Apr 17, 2025, 5:30 PM CET
ETR:1SXP Revenue
SCHOTT Pharma AG & Co. KGaA had revenue of 229.84M EUR in the quarter ending December 31, 2024, a decrease of -1.04%. This brings the company's revenue in the last twelve months to 954.68M, up 5.42% year-over-year. In the fiscal year ending September 30, 2024, SCHOTT Pharma AG & Co. KGaA had annual revenue of 957.09M with 6.51% growth.
Revenue (ttm)
954.68M
Revenue Growth
+5.42%
P/S Ratio
3.64
Revenue / Employee
201.03K
Employees
4,690
Market Cap
3.47B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 957.09M | 58.49M | 6.51% |
Sep 30, 2023 | 898.60M | 77.46M | 9.43% |
Sep 30, 2022 | 821.14M | 172.48M | 26.59% |
Sep 30, 2021 | 648.67M | 64.44M | 11.03% |
Sep 30, 2020 | 584.23M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck KGaA | 21.16B |
Siemens Healthineers AG | 22.67B |
Fresenius SE & Co. KGaA | 21.83B |
Bayer Aktiengesellschaft | 46.61B |
Sartorius Aktiengesellschaft | 3.44B |
Fresenius Medical Care AG | 19.34B |
Carl Zeiss Meditec AG | 2.08B |
Fielmann Group AG | 2.16B |
SCHOTT Pharma AG & Co. KGaA News
- 10 days ago - SCHOTT Pharma Exceeds Market Expectations in Q2 2025 - Wallstreet:Online
- 10 days ago - EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma: Preliminary Q2 2025 figures exceed capital market expectations - Wallstreet:Online
- 11 days ago - EQS-News: Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe - Wallstreet:Online
- 19 days ago - EQS-AFR: SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] - Wallstreet:Online
- 2 months ago - SCHOTT Pharma's Strong Q1: Confirms 2023 Outlook - Wallstreet:Online
- 2 months ago - EQS-News: SCHOTT Pharma records good start into fiscal year and confirms full year outlook - Wallstreet:Online
- 2 months ago - SCHOTT Pharma AG & Co. KGaA goes ex dividend tomorrow - Seeking Alpha
- 2 months ago - EQS-News: SCHOTT Pharma with successful Annual General Meeting: Shareholders approve all agenda items - Wallstreet:Online